Monitoring Autophagic Flux by Using Lysosomal Inhibitors and Western Blotting of Endogenous MAP1LC3B
Open Access
- 3 August 2015
- journal article
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Protocols
- Vol. 2015 (8) , 743-50
Abstract
Assays that monitor autophagic flux, or degradative completion of autophagy, are crucial for the assessment of the dynamic autophagy process in a variety of systems. Such assays help to distinguish between an increase in autophagosomes resulting from induced autophagic activity versus an increase in autophagosomes due to reduced lysosomal turnover. The majority of flux assays use autophagy protein MAP1LC3B (microtubule-associated proteins 1A/1B light chain 3B, here referred to as LC3B) as a marker for autophagy, and most are based on the use of reporters. Here, we describe a method, suitable for monitoring flux in primary cells and/or when reporters are not available or desirable, that uses lysosomal inhibitors and the analysis of endogenous LC3B-II (the lipidated form of LC3B that is associated with autophagosomes) by western blotting. A common application of this method, detailed here, is to test whether a treatment of interest (e.g., chemotherapy drug) induces autophagic flux in the cells of interest. If it is found that there is no difference in LC3B-II levels between treatment with lysosomal inhibitor alone versus drug plus lysosomal inhibitor, then this suggests that the drug is not inducing autophagic flux. Elevated levels of LC3B-II in treatments with drug plus lysosomal inhibitor, compared with drug treatment alone and inhibitor treatment alone, indicate that the drug is probably leading to an increase in autophagic flux.Keywords
This publication has 12 references indexed in Scilit:
- Monitoring the Localization of MAP1LC3B by Indirect ImmunofluorescenceCold Spring Harbor Protocols, 2015
- Detection of p62 on Paraffin Sections by ImmunohistochemistryCold Spring Harbor Protocols, 2015
- Monitoring Autophagic Flux Using Ref(2)P, the Drosophila p62 OrthologCold Spring Harbor Protocols, 2014
- Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiencyProceedings of the National Academy of Sciences, 2012
- In search of an “autophagomometer”Autophagy, 2009
- Protective role of autophagy against Vibrio cholerae cytolysin, a pore-forming toxin from V. choleraeProceedings of the National Academy of Sciences, 2007
- Generation of cell lines with tetracycline‐regulated autophagy and a role for autophagy in controlling cell sizeFEBS Letters, 2006
- Lysosomal Turnover, but Not a Cellular Level, of Endogenous LC3 is a Marker for AutophagyAutophagy, 2005
- Cargo Proteins Facilitate the Formation of Transport Vesicles in the Cytoplasm to Vacuole Targeting PathwayJournal of Biological Chemistry, 2004
- LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processingThe EMBO Journal, 2000